Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Abzena Selects IPS for Turnkey Delivery of Their New CGMP Facility in North Carolina
IPS-Integrated Project Services, LLC, a provider of engineering, procurement, construction management, and validation (EPCMV) services, announces its support to ...
read more
Abzena has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm.
read more
Monday, December 20, 2021
Abzena, the leading Partner Research Organization (PRO) for outsourced solutions integrating gene to commercial for large molecules and bioconjugates, announced it has promoted Troy Wright to Senior Vice President and Global Head of Quality. ...
read more
Wednesday, October 27, 2021
Abzena, the leading Partner Research Organization (PRO) for outsourced solutions integrating gene to commercial for large molecules and bioconjugates, announced it has promoted Dr. Louise Duffy as Chief Technical Officer.
read more
Abzena announced the completion of the facility remodeling for its new antibody-drug conjugate GMP manufacturing suite at its Bristol, Pennsylvania site.
read more
Tuesday, February 01, 2022
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Kevin Lundquist as Chief Financial Officer, effective January 31, 2022...
read more
Tuesday, January 25, 2022
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Jim Kennamer as Senior Vice President and Site Head of North Carolina.
read more
Wednesday, August 19, 2020
Abzena has announced the appointment of Anu Bansal as Senior Director of Manufacturing at its facility in Bristol, Pennsylvania.
read more
Abzena has invested $60m into a new facility for late phase and commercial cGMP manufacturing.
read more
Abzena announced an accelerated program to IND.
read more
Wednesday, September 25, 2013
Recipharm Stockholm is pleased to announce that the company was informed on September 20, 2013 by the R&D-based pharmaceutical company, Kyowa Hakko Kirin Co. Ltd. (Tokyo, Japan, President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) that Abstral® ...
read more
Wednesday, October 05, 2022
Absolute Biotech has launched as a unified company joining together leading antibody-centric brands from around the world.
read more
Tuesday, February 28, 2023
Absci Corporation, a generative AI drug creation company, announced its expansion into the European pharmaceutical market with the opening of its Innovation Center, located in Zug, Switzerland.
read more
Ablexis, LLC and AlivaMab Discovery Services, LLC announced a multi-target licensing agreement between Ablexis and Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, and a research partnership between ADS and Almirall.
read more
Wednesday, October 16, 2019
ABL announced the company was awarded an IDIQ contract by the NCI of the NIH under its PREVENT Cancer Preclinical Drug Development Program.
read more